FRIDAY, June 4, 2021 (HealthDay News) — A newly approved lung cancer drug shows promise in improving survival in patients whose tumors carry a common and tough-to-treat genetic mutation, researchers say. Sotorasib — brand name Lumakras — was approved May 28 by the U.S. Food and Drug Administration as aContinue Reading

FRIDAY, June 4, 2021 (HealthDay News) — A twice-daily pill can dramatically reduce the risk of breast cancer recurrence in women who are genetically prone to the disease, researchers report. The pill — olaparib (Lynparza) — works by blocking a natural enzyme called PARP that normally fixes DNA damage inContinue Reading

THURSDAY, June 3, 2021 (HealthDay News) — Reacting to recent controversy, the American Medical Association (AMA) announced Thursday a series of steps it will take to promote diversity, equity and inclusion within the medical society and its network of 12 influential journals. Dr. Howard Bauchner, editor-in-chief of the Journal ofContinue Reading

WEDNESDAY, June 2, 2021 (HealthDay News) — Moderna plus Pfizer? J&J plus Moderna? There’s a new clinical trial underway to assess the safety and effectiveness of mixing different types of booster shots in adults who have been fully vaccinated against COVID-19. “Although the vaccines currently authorized by the U.S. FoodContinue Reading

TUESDAY, June 1, 2021 (HealthDay News) — COVID-19 does not pose a threat to the safety of the United States’ blood supply under existing donor screening guidelines, researchers report. For the study, the investigators reviewed the results of tests for the presence of SARS-CoV-2 in nearly 18,000 pools of donatedContinue Reading

FRIDAY, May 28, 2021 (HealthDay News) — Many health experts hailed the recent approval of the Pfizer vaccine for those aged 12 to 15, but some parents have been hesitant to take their kids in for a shot. “Parents naturally worry more about their children than they do about themselvesContinue Reading

THURSDAY, May 27, 2021 (HealthDay News) — An experimental antibody therapy may help ease skin symptoms from the autoimmune disease lupus, a small preliminary trial suggests. Researchers found that a higher-dose version of the drug spurred a “clinically meaningful” symptom improvement for 87% of patients after one month. But theyContinue Reading

THURSDAY, May 27, 2021 (HealthDay News) — Patients facing relatively simple outpatient surgeries are nonetheless being told to undergo a number of preoperative tests that just aren’t necessary, a new study reports. More than half of a group of patients facing low-risk outpatient surgery received one or more tests —Continue Reading